L3VLUP
ProSign in

INMD · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

INMDLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • INMD
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterINMDLLY
Q3 20201 holders, $876k33 holders, $14.1bn
Q4 20205 holders, $37m29 holders, $17.3bn
Q1 202112 holders, $245m24 holders, $23.0bn
Q2 202111 holders, $360m24 holders, $27.8bn
Q3 202114 holders, $734m31 holders, $29.9bn
Q4 202112 holders, $695m31 holders, $34.7bn
Q1 202213 holders, $471m24 holders, $35.3bn
Q2 202210 holders, $287m33 holders, $42.7bn
Q3 202210 holders, $271m31 holders, $43.4bn
Q4 20227 holders, $263m31 holders, $46.6bn
Q1 20239 holders, $248m33 holders, $44.3bn
Q2 20237 holders, $247m37 holders, $59.6bn
Q3 20236 holders, $159m44 holders, $67.6bn
Q4 20234 holders, $81m45 holders, $73.6bn
Q1 20244 holders, $77m41 holders, $95.3bn
Q2 20245 holders, $81m43 holders, $110bn
Q3 20245 holders, $66m45 holders, $107bn
Q4 20244 holders, $63m46 holders, $93.9bn
Q1 20253 holders, $53m42 holders, $98.4bn
Q2 20254 holders, $39m43 holders, $93.2bn
Q3 20253 holders, $68m39 holders, $86.7bn
Q4 20253 holders, $76m41 holders, $123bn
Q1 20263 holders, $73m39 holders, $106bn
Q2 20263 holders, $75m44 holders, $132bn
INMD

Inmode LTD

Holders
4
Reported value
$81m
Buyers
2
Sellers
2

Breadth 0 among 93 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
LLY

Eli Lilly & Co

Holders
45
Reported value
$73.6bn
Buyers
27
Sellers
21

Breadth +6 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q4 2023

Among the 47 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only INMD (2)

ARK Investment Management LLC, Winton Group Ltd

Only LLY (43)

AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Citadel Advisors LLC, Coatue Management LLC, D. E. Shaw & Co., Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), GAMCO Investors Inc, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, Maverick Capital Ltd, MFS Investment Management, and 18 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →